
USD/CHF: Here’s why Swiss franc has jumped to a 14-year high
The Swiss franc has gone vertical this year as it became a refuge to most investors as global risks jumped. The USD/CHF exchange rate plunged to a low of 0.8140 on Friday, its lowest level since 2011. It has fallen by almost 12% from its highest level in 2024. Swiss franc as a safe haven […]
- April 10, 2025 05:02 PM PDT
- Invezz

IBM Informs Staff of DEI Retreat as Trump-Era Scrutiny Grows
(Bloomberg) -- International Business Machines Corp. spent months revising its diversity initiatives as conservative attacks and souring attitudes toward DEI shifted into a full-blown assault from Pre...
- April 10, 2025 04:30 PM PDT
- EODHD

Is the Entertainment Tech Space Facing More Volatility Now?
Is the Entertainment Tech Space Facing More Volatility Now?
- April 10, 2025 04:16 PM PDT
- Team Kalkine Media

Is Aerospace Equipment Facing New Pressure In Market Trends?
Is Aerospace Equipment Facing New Pressure in Market Trends?
- April 10, 2025 04:13 PM PDT
- Team Kalkine Media

Is Retail Pressure Weighing On Kontoor’s Legacy Brands?
Is Retail Pressure Weighing on Kontoor’s Legacy Brands?
- April 10, 2025 04:09 PM PDT
- Team Kalkine Media

Could Logistics Demand Shifts Be Impacting RXO?
Could Logistics Demand Shifts Be Impacting RXO?
- April 10, 2025 04:02 PM PDT
- Team Kalkine Media

Could Funding Pressure Be Impacting Hannon Armstrong?
Could Funding Pressure Be Impacting Hannon Armstrong?
- April 10, 2025 03:58 PM PDT
- Team Kalkine Media

What’s Driving This Real Estate Stock To Fresh Lows Now?
What’s Driving This Real Estate Stock to Fresh Lows Now?
- April 10, 2025 03:55 PM PDT
- Team Kalkine Media

Why Is This Financial Stock Touching New Lows Again?
Why Is This Financial Stock Touching New Lows Again?
- April 10, 2025 03:52 PM PDT
- Team Kalkine Media

Halozyme Announces FDA Approval of argenx's VYVGART® Hytrulo Prefilled Syringe Co-Formulated with ENHANZE® for Self-Injection for Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy
SAN DIEGO, April 10, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that argenx has received U.S. Food and Drug Administration (FDA) approval of VYVGART® Hy...
- April 10, 2025 03:15 PM PDT
- EODHD